<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:d="http://xbrl.dcca.dk/sob" xmlns:b="http://xbrl.dcca.dk/entryBalanceSheetAccountFormIncomeStatementByNature" xmlns:h="http://xbrl.dcca.dk/mrv" xmlns:g="http://xbrl.dcca.dk/cmn" xmlns:f="http://xbrl.dcca.dk/arr" xmlns:e="http://xbrl.dcca.dk/gsd" xmlns:c="http://xbrl.dcca.dk/fsa" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://xbrl.dcca.dk/entryBalanceSheetAccountFormIncomeStatementByNature entryDanishGAAPBalanceSheetAccountFormIncomeStatementByNatureIncludingManagementsReviewStatisticsAndTax20201001.xsd"><link:schemaRef xlink:type="simple" xlink:href="http://archprod.service.eogs.dk/taxonomy/20201001/entryDanishGAAPBalanceSheetAccountFormIncomeStatementByNatureIncludingManagementsReviewStatisticsAndTax20201001.xsd"/><c:AccountingPoliciesAreUnchangedFromPreviousPeriod contextRef="c405">true</c:AccountingPoliciesAreUnchangedFromPreviousPeriod><d:TheReportingEntityAppliesTheExceptionConcerningOptingOutOfTheStatementByManagementEtc contextRef="c405">false</d:TheReportingEntityAppliesTheExceptionConcerningOptingOutOfTheStatementByManagementEtc><e:NameAndSurnameOfChairmanOfGeneralMeeting contextRef="c405">Mikael Schiller</e:NameAndSurnameOfChairmanOfGeneralMeeting><e:InformationOnTypeOfSubmittedReport contextRef="c405">Årsrapport</e:InformationOnTypeOfSubmittedReport><e:IdentificationNumberCvrOfSubmittingEnterprise contextRef="c405">25578198</e:IdentificationNumberCvrOfSubmittingEnterprise><e:NameOfSubmittingEnterprise contextRef="c405">KPMG</e:NameOfSubmittingEnterprise><e:AddressOfSubmittingEnterpriseStreetAndNumber contextRef="c405">Dampfærgevej 28</e:AddressOfSubmittingEnterpriseStreetAndNumber><e:AddressOfSubmittingEnterprisePostcodeAndTown contextRef="c405">DK-2100 København Ø</e:AddressOfSubmittingEnterprisePostcodeAndTown><e:ReportingPeriodStartDate contextRef="c405">2022-09-01</e:ReportingPeriodStartDate><e:ReportingPeriodEndDate contextRef="c405">2023-08-31</e:ReportingPeriodEndDate><e:PrecedingReportingPeriodStartDate contextRef="c405">2021-09-01</e:PrecedingReportingPeriodStartDate><e:PredingReportingPeriodEndDate contextRef="c405">2022-08-31</e:PredingReportingPeriodEndDate><f:SignatureOfAuditorsDate contextRef="c405">2023-12-04</f:SignatureOfAuditorsDate><d:DateOfApprovalOfAnnualReport contextRef="c405">2023-12-04</d:DateOfApprovalOfAnnualReport><e:IdentificationNumberCvrOfReportingEntity contextRef="c405">28106483</e:IdentificationNumberCvrOfReportingEntity><e:NameOfReportingEntity contextRef="c405">Acne Denmark ApS</e:NameOfReportingEntity><e:AddressOfReportingEntityStreetName contextRef="c405">Pilestræde 40B, </e:AddressOfReportingEntityStreetName><e:AddressOfReportingEntityStreetBuildingIdentifier contextRef="c405">1.</e:AddressOfReportingEntityStreetBuildingIdentifier><e:AddressOfReportingEntityPostCodeIdentifier contextRef="c405">1112</e:AddressOfReportingEntityPostCodeIdentifier><e:AddressOfReportingEntityDistrictName contextRef="c405">København K</e:AddressOfReportingEntityDistrictName><e:AddressOfReportingEntityCountryIdentificationCode contextRef="c405">DK</e:AddressOfReportingEntityCountryIdentificationCode><e:AddressOfReportingEntityCountry contextRef="c405">Denmark</e:AddressOfReportingEntityCountry><e:DateOfFoundationOfReportingEntity contextRef="c405">2004-09-06</e:DateOfFoundationOfReportingEntity><e:RegisteredOfficeOfReportingEntity contextRef="c405">Copenhagen</e:RegisteredOfficeOfReportingEntity><e:TelephoneNumberOfReportingEntity contextRef="c405">33140030</e:TelephoneNumberOfReportingEntity><e:HomepageOfReportingEntity contextRef="c405">www.acnestudios.com</e:HomepageOfReportingEntity><e:NameOfFinancialInstitution contextRef="c405">Nordea Bank International Branch </e:NameOfFinancialInstitution><e:AddressOfFinancialStreetName contextRef="c405">Meldalhlsgade 1</e:AddressOfFinancialStreetName><e:AddressOfFinancialPostCodeIdentifier contextRef="c405">1613</e:AddressOfFinancialPostCodeIdentifier><e:NameOfLawFirm contextRef="c405">Rønne &amp; Lundgren</e:NameOfLawFirm><e:AddressOfLawFirmStreetName contextRef="c405">Tuborg Havnevej</e:AddressOfLawFirmStreetName><e:AddressOfLawFirmStreetBuildingIdentifier contextRef="c405">19</e:AddressOfLawFirmStreetBuildingIdentifier><e:AddressOfLawFirmPostCodeIdentifier contextRef="c405">2900</e:AddressOfLawFirmPostCodeIdentifier><e:AddressOfLawFirmDistrictName contextRef="c405">Hellerup</e:AddressOfLawFirmDistrictName><g:NameOfAuditFirm contextRef="c407">KPMG</g:NameOfAuditFirm><g:IdentificationNumberCvrOfAuditFirm contextRef="c407">25578198</g:IdentificationNumberCvrOfAuditFirm><g:NameAndSurnameOfAuditor contextRef="c407">Anja Bjørnholt Lüthcke</g:NameAndSurnameOfAuditor><g:IdentificationNumberOfAuditor contextRef="c407">mne26779</g:IdentificationNumberOfAuditor><g:DescriptionOfAuditor contextRef="c407">statsaut. revisor</g:DescriptionOfAuditor><e:AddressOfAuditorStreetName contextRef="c407">Dampfærgevej</e:AddressOfAuditorStreetName><e:AddressOfAuditorStreetBuildingIdentifier contextRef="c407">28</e:AddressOfAuditorStreetBuildingIdentifier><e:AddressOfAuditorPostCodeIdentifier contextRef="c407">2100</e:AddressOfAuditorPostCodeIdentifier><e:AddressOfAuditorDistrictName contextRef="c407">Copenhagen</e:AddressOfAuditorDistrictName><e:AddressOfAuditorCountryIdentificationCode contextRef="c407">DK</e:AddressOfAuditorCountryIdentificationCode><e:AddressOfAuditorCountry contextRef="c405">Denmark</e:AddressOfAuditorCountry><e:TelephoneNumberOfAuditor contextRef="c407">4570707760</e:TelephoneNumberOfAuditor><e:DateOfGeneralMeeting contextRef="c405">2023-12-04</e:DateOfGeneralMeeting><c:ClassOfReportingEntity contextRef="c405">Regnskabsklasse B</c:ClassOfReportingEntity><c:SelectedElementsFromReportingClassC contextRef="c405">false</c:SelectedElementsFromReportingClassC><c:SelectedElementsFromReportingClassD contextRef="c405">false</c:SelectedElementsFromReportingClassD><g:TypeOfAuditorAssistance contextRef="c405" xml:lang="da">Revisionspåtegning</g:TypeOfAuditorAssistance><d:IdentificationOfApprovedAnnualReport contextRef="c405" xml:lang="en">The Board of Directors and the Executive Board have today discussed and approved the annual report of Acne Denmark ApS for the financial year 1 September 2022 – 31 August 2023.</d:IdentificationOfApprovedAnnualReport><d:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement contextRef="c405" xml:lang="en">The annual report has been prepared in accordance with the Danish Financial Statements Act.</d:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement><d:RecommendationForApprovalOfAnnualReportByGeneralMeeting contextRef="c405" xml:lang="en">We recommend that the annual report be approved at the annual general meeting.</d:RecommendationForApprovalOfAnnualReportByGeneralMeeting><d:PlaceOfSignatureOfStatement contextRef="c405" xml:lang="en">Copenhagen,</d:PlaceOfSignatureOfStatement><g:NameAndSurnameOfMemberOfExecutiveBoard contextRef="c428">Tommy Mattias Magnusson</g:NameAndSurnameOfMemberOfExecutiveBoard><g:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="c434">Mikael Fabian Schiller</g:NameAndSurnameOfMemberOfSupervisoryBoard><g:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="c435">Carl Jonny Stefan Johannsson</g:NameAndSurnameOfMemberOfSupervisoryBoard><g:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="c436">Tommy Mattias Magnusson</g:NameAndSurnameOfMemberOfSupervisoryBoard><f:AddresseeOfAuditorsReportOnAuditedFinancialStatements contextRef="c405" xml:lang="en">To the shareholders of Acne Denmark ApS</f:AddresseeOfAuditorsReportOnAuditedFinancialStatements><f:TypeOfModifiedOpinionOnAuditedFinancialStatements contextRef="c405">Opinion</f:TypeOfModifiedOpinionOnAuditedFinancialStatements><f:TypeOfBasisForModifiedOpinionOnAuditedFinancialStatements contextRef="c405">Basis for Opinion</f:TypeOfBasisForModifiedOpinionOnAuditedFinancialStatements><f:DescriptionOfQualificationsOfAuditedFinancialStatements contextRef="c405" xml:lang="en">We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the "Auditor's responsibilities for the audit of the financial statements" section of our report. 
We are independent of the Company in accordance with the International Ethics Standards Board for Accountants' International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.</f:DescriptionOfQualificationsOfAuditedFinancialStatements><f:SignatureOfAuditorsPlace contextRef="c405" xml:lang="en">Copenhagen,</f:SignatureOfAuditorsPlace><c:GrossProfitLoss contextRef="c405" unitRef="u14" decimals="-3">5219000</c:GrossProfitLoss><c:GrossProfitLoss contextRef="c409" unitRef="u14" decimals="-3">4487000</c:GrossProfitLoss><c:EmployeeBenefitsExpense contextRef="c405" unitRef="u14" decimals="-3">4705000</c:EmployeeBenefitsExpense><c:EmployeeBenefitsExpense contextRef="c409" unitRef="u14" decimals="-3">3865000</c:EmployeeBenefitsExpense><c:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss contextRef="c405" unitRef="u14" decimals="-3">72000</c:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss><c:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss contextRef="c409" unitRef="u14" decimals="-3">63000</c:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss><c:ProfitLossFromOrdinaryOperatingActivities contextRef="c405" unitRef="u14" decimals="-3">442000</c:ProfitLossFromOrdinaryOperatingActivities><c:ProfitLossFromOrdinaryOperatingActivities contextRef="c409" unitRef="u14" decimals="-3">559000</c:ProfitLossFromOrdinaryOperatingActivities><c:OtherFinanceIncome contextRef="c405" unitRef="u14" decimals="-3">5000</c:OtherFinanceIncome><c:OtherFinanceIncome contextRef="c409" unitRef="u14" decimals="-3">3000</c:OtherFinanceIncome><c:OtherFinanceExpenses contextRef="c405" unitRef="u14" decimals="-3">13000</c:OtherFinanceExpenses><c:OtherFinanceExpenses contextRef="c409" unitRef="u14" decimals="-3">52000</c:OtherFinanceExpenses><c:ProfitLossFromOrdinaryActivitiesBeforeTax contextRef="c405" unitRef="u14" decimals="-3">434000</c:ProfitLossFromOrdinaryActivitiesBeforeTax><c:ProfitLossFromOrdinaryActivitiesBeforeTax contextRef="c409" unitRef="u14" decimals="-3">510000</c:ProfitLossFromOrdinaryActivitiesBeforeTax><c:TaxExpense contextRef="c405" unitRef="u14" decimals="-3">95000</c:TaxExpense><c:TaxExpense contextRef="c409" unitRef="u14" decimals="-3">113000</c:TaxExpense><c:ProfitLoss contextRef="c405" unitRef="u14" decimals="-3">339000</c:ProfitLoss><c:ProfitLoss contextRef="c409" unitRef="u14" decimals="-3">397000</c:ProfitLoss><c:ProfitLoss contextRef="c447" unitRef="u14" decimals="-3">339000</c:ProfitLoss><c:ProfitLoss contextRef="c448" unitRef="u14" decimals="-3">397000</c:ProfitLoss><c:FixturesFittingsToolsAndEquipment contextRef="c412" unitRef="u14" decimals="-3">189000</c:FixturesFittingsToolsAndEquipment><c:FixturesFittingsToolsAndEquipment contextRef="c413" unitRef="u14" decimals="-3">248000</c:FixturesFittingsToolsAndEquipment><c:LeaseholdImprovements contextRef="c412" unitRef="u14" decimals="-3">15000</c:LeaseholdImprovements><c:LeaseholdImprovements contextRef="c413" unitRef="u14" decimals="-3">27000</c:LeaseholdImprovements><c:PropertyPlantAndEquipment contextRef="c412" unitRef="u14" decimals="-3">204000</c:PropertyPlantAndEquipment><c:PropertyPlantAndEquipment contextRef="c413" unitRef="u14" decimals="-3">275000</c:PropertyPlantAndEquipment><c:DepositsLongtermInvestmentsAndReceivables contextRef="c412" unitRef="u14" decimals="-3">33000</c:DepositsLongtermInvestmentsAndReceivables><c:DepositsLongtermInvestmentsAndReceivables contextRef="c413" unitRef="u14" decimals="-3">33000</c:DepositsLongtermInvestmentsAndReceivables><c:NoncurrentAssets contextRef="c412" unitRef="u14" decimals="-3">237000</c:NoncurrentAssets><c:NoncurrentAssets contextRef="c413" unitRef="u14" decimals="-3">308000</c:NoncurrentAssets><c:ManufacturedGoodsAndGoodsForResale contextRef="c412" unitRef="u14" decimals="-3">5823000</c:ManufacturedGoodsAndGoodsForResale><c:ManufacturedGoodsAndGoodsForResale contextRef="c413" unitRef="u14" decimals="-3">4967000</c:ManufacturedGoodsAndGoodsForResale><c:ShorttermReceivablesFromGroupEnterprises contextRef="c412" unitRef="u14" decimals="-3">5726000</c:ShorttermReceivablesFromGroupEnterprises><c:ShorttermReceivablesFromGroupEnterprises contextRef="c413" unitRef="u14" decimals="-3">4168000</c:ShorttermReceivablesFromGroupEnterprises><c:OtherShorttermReceivables contextRef="c412" unitRef="u14" decimals="-3">953000</c:OtherShorttermReceivables><c:OtherShorttermReceivables contextRef="c413" unitRef="u14" decimals="-3">835000</c:OtherShorttermReceivables><c:CurrentDeferredTaxAssets contextRef="c412" unitRef="u14" decimals="-3">295000</c:CurrentDeferredTaxAssets><c:CurrentDeferredTaxAssets contextRef="c413" unitRef="u14" decimals="-3">390000</c:CurrentDeferredTaxAssets><c:ShorttermTaxReceivables contextRef="c412" unitRef="u14" decimals="-3">1114000</c:ShorttermTaxReceivables><c:ShorttermTaxReceivables contextRef="c413" unitRef="u14" decimals="-3">102000</c:ShorttermTaxReceivables><c:DeferredIncomeAssets contextRef="c412" unitRef="u14" decimals="-3">405000</c:DeferredIncomeAssets><c:DeferredIncomeAssets contextRef="c413" unitRef="u14" decimals="-3">410000</c:DeferredIncomeAssets><c:ShorttermReceivables contextRef="c412" unitRef="u14" decimals="-3">8493000</c:ShorttermReceivables><c:ShorttermReceivables contextRef="c413" unitRef="u14" decimals="-3">5905000</c:ShorttermReceivables><c:CashAndCashEquivalents contextRef="c412" unitRef="u14" decimals="-3">1482000</c:CashAndCashEquivalents><c:CashAndCashEquivalents contextRef="c413" unitRef="u14" decimals="-3">2707000</c:CashAndCashEquivalents><c:CurrentAssets contextRef="c412" unitRef="u14" decimals="-3">15798000</c:CurrentAssets><c:CurrentAssets contextRef="c413" unitRef="u14" decimals="-3">13579000</c:CurrentAssets><c:Assets contextRef="c412" unitRef="u14" decimals="-3">16035000</c:Assets><c:Assets contextRef="c413" unitRef="u14" decimals="-3">13887000</c:Assets><c:ContributedCapital contextRef="c412" unitRef="u14" decimals="-3">125000</c:ContributedCapital><c:ContributedCapital contextRef="c413" unitRef="u14" decimals="-3">125000</c:ContributedCapital><c:RetainedEarnings contextRef="c412" unitRef="u14" decimals="-3">11172000</c:RetainedEarnings><c:RetainedEarnings contextRef="c413" unitRef="u14" decimals="-3">10833000</c:RetainedEarnings><c:Equity contextRef="c412" unitRef="u14" decimals="-3">11297000</c:Equity><c:Equity contextRef="c413" unitRef="u14" decimals="-3">10958000</c:Equity><c:ShorttermPrepaymentsReceivedFromCustomers contextRef="c412" unitRef="u14" decimals="-3">183000</c:ShorttermPrepaymentsReceivedFromCustomers><c:ShorttermPrepaymentsReceivedFromCustomers contextRef="c413" unitRef="u14" decimals="-3">259000</c:ShorttermPrepaymentsReceivedFromCustomers><c:ShorttermTradePayables contextRef="c412" unitRef="u14" decimals="-3">73000</c:ShorttermTradePayables><c:ShorttermTradePayables contextRef="c413" unitRef="u14" decimals="-3">93000</c:ShorttermTradePayables><c:OtherShorttermPayables contextRef="c412" unitRef="u14" decimals="-3">4482000</c:OtherShorttermPayables><c:OtherShorttermPayables contextRef="c413" unitRef="u14" decimals="-3">2577000</c:OtherShorttermPayables><c:ShorttermLiabilitiesOtherThanProvisions contextRef="c412" unitRef="u14" decimals="-3">4738000</c:ShorttermLiabilitiesOtherThanProvisions><c:ShorttermLiabilitiesOtherThanProvisions contextRef="c413" unitRef="u14" decimals="-3">2929000</c:ShorttermLiabilitiesOtherThanProvisions><c:LiabilitiesOtherThanProvisions contextRef="c412" unitRef="u14" decimals="-3">4738000</c:LiabilitiesOtherThanProvisions><c:LiabilitiesOtherThanProvisions contextRef="c413" unitRef="u14" decimals="-3">2929000</c:LiabilitiesOtherThanProvisions><c:LiabilitiesAndEquity contextRef="c412" unitRef="u14" decimals="-3">16035000</c:LiabilitiesAndEquity><c:LiabilitiesAndEquity contextRef="c413" unitRef="u14" decimals="-3">13887000</c:LiabilitiesAndEquity><c:Equity contextRef="c491" unitRef="u14" decimals="-3">125000</c:Equity><c:Equity contextRef="c621" unitRef="u14" decimals="-3">10833000</c:Equity><c:ProfitLoss contextRef="c487" unitRef="u14" decimals="-3">0</c:ProfitLoss><c:ProfitLoss contextRef="c617" unitRef="u14" decimals="-3">339000</c:ProfitLoss><c:Equity contextRef="c494" unitRef="u14" decimals="-3">125000</c:Equity><c:Equity contextRef="c624" unitRef="u14" decimals="-3">11172000</c:Equity><c:AverageNumberOfEmployees contextRef="c405" unitRef="u16" decimals="0">13</c:AverageNumberOfEmployees><c:AverageNumberOfEmployees contextRef="c409" unitRef="u16" decimals="0">10</c:AverageNumberOfEmployees><c:DisclosureOfRelatedParties contextRef="c405" xml:lang="en">Control
Acne Denmark ApS related parties comprise the following:
Acne Denmark ApS' is part of the consolidated financial statements of Acne Studios AB, Floragatan 13, 114 31 Stockholm, Sverige, which is the smallest group, in which the Company is included as a subsidiary.

The consolidated financial statements of Acne Studios AB can be obtained by contacting the Company at the address above.</c:DisclosureOfRelatedParties><d:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults contextRef="c405" xml:lang="en">In our opinion, the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 August 2023 and of the results of the Company's operations for the financial year 1 September 2022 – 31 August 2023.
Further, in our opinion, the Management's review gives a fair review of the matters discussed in the Management's review.</d:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults><f:OpinionOnAuditedFinancialStatements contextRef="c405" xml:lang="en">We have audited the financial statements of Acne Denmark ApS for the financial year 1 September 2022 – 31 August 2023 comprising income statement, balance sheet, statement of changes in equity and notes, including accounting policies. The financial statements are prepared in accordance with the Danish Financial Statements Act.
In our opinion, the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 August 2023 and of the results of the Company's operations for the financial year 1 September 2022 – 31 August 2023 in accordance with the Danish Financial Statements Act.</f:OpinionOnAuditedFinancialStatements><f:StatementOfExecutiveAndSupervisoryBoardsResponsibilityForFinancialStatements contextRef="c405" xml:lang="en">Management is responsible for the preparation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act and for such internal control that Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, Management is responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting in preparing the financial statements unless Management either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.</f:StatementOfExecutiveAndSupervisoryBoardsResponsibilityForFinancialStatements><f:StatementOfAuditorsResponsibilityForAuditAndAuditPerformed contextRef="c405" xml:lang="en">Our objectives are to obtain reasonable assurance as to whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs and the additional requirements in Denmark will always detect a material misstatement when it exists. Misstatements may arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of financial statement users made on the basis of these financial statements.
As part of an audit conducted in accordance with ISAs and the additional requirements applicable in Denmark, we exercise professional judgement and maintain professional scepticism throughout the audit. We also

identify and assess the risks of material misstatement of the company financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error as fraud may involve collusion, forgery, intentional omissions, misrepresentations or the override of internal control.
obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control.
evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by Management.
conclude on the appropriateness of Management's use of the going concern basis of accounting in preparing the financial statements and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Company to cease to continue as a going concern.
evaluate the overall presentation, structure and contents of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that gives a true and fair view.
We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.</f:StatementOfAuditorsResponsibilityForAuditAndAuditPerformed><f:StatementOnManagementsReviewAuditorsReportOnAuditedFinancialStatements contextRef="c405" xml:lang="en">Management is responsible for the Management's review.
Our opinion on the financial statements does not cover the Management's review, and we do not express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, our responsibility is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated.
Moreover, it is our responsibility to consider whether the Management's review provides the information required under the Danish Financial Statements Act.
Based on the work we have performed, we conclude that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement of the Management's review. </f:StatementOnManagementsReviewAuditorsReportOnAuditedFinancialStatements><h:DescriptionOfPrimaryActivitiesOfEntity contextRef="c405" xml:lang="en">As in previous years, the Company's main activity has consisted of trading within the clothing industry.</h:DescriptionOfPrimaryActivitiesOfEntity><h:DescriptionOfDevelopmentInActivitiesAndFinancialAffairs contextRef="c405" xml:lang="en">The Company's income statement for 2022/23 shows a profit of DKK 339 thousand as against DKK 397 thousand in 2021/22. Equity in the Company's balance sheet at 31 August 2023 stood at DKK 11,297 thousand as against DKK 10,958 thousand at 31 August 2022.
The fiscal year has been characterized by a continued recovery from the earlier pandemic, although with limited tourist flows within the retail business relative to pre-Covid levels. No COVID-19 government support has been received during the fiscal year.</h:DescriptionOfDevelopmentInActivitiesAndFinancialAffairs><h:DescriptionOfSignificantEventsOccurringAfterEndOfReportingPeriod contextRef="c405" xml:lang="en">No events have occurred after the balance sheet date of material importance to the annual report for 2022/23. </h:DescriptionOfSignificantEventsOccurringAfterEndOfReportingPeriod><c:InformationOnReportingClassOfEntity contextRef="c405" xml:lang="en">The annual report of Acne Denmark ApS for 2022/23 has been prepared in accordance with the provisions applying to reporting class B entities under the Danish Financial Statements Act with opt-in from higher reporting classes.</c:InformationOnReportingClassOfEntity><c:DisclosureOfAccountingPolicies contextRef="c405" xml:lang="en">The accounting policies used in the preparation of the financial statements are consistent with those of last year.</c:DisclosureOfAccountingPolicies><c:DescriptionOfMethodsOfForeignCurrencies contextRef="c405">On initial recognition, transactions denominated in foreign currencies are translated at the exchange rates at the transaction date. Foreign exchange differences arising between the exchange rates at the transaction date and the date of payment are recognised in the income statement as financial income or financial expenses.

Receivables, payables and other monetary items denominated in foreign currencies are translated at the exchange rates at the balance sheet date. The difference between the exchange rates at the balance sheet date and the date at which the receivable or payable arose or was recognised in the latest financial statements is recognised in the income statement as financial income or financial expenses.</c:DescriptionOfMethodsOfForeignCurrencies><c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfGrossProfitLoss contextRef="c405" xml:lang="en">Pursuant to section 32 of the Danish Financial Statements Act, the Company has decided only to disclose gross profit.

Gross profit comprises revenue, cost of sales, other operating income and other external costs.</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfGrossProfitLoss><c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfRevenue contextRef="c405" xml:lang="en">Income from the sale of goods, is recognised in revenue when delivery and transfer of risk to the buyer have taken place, and the income may be measured reliably and is expected to be received. </c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfRevenue><c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCostOfSales contextRef="c405" xml:lang="en">Cost of sales comprises costs incurred to generate revenue for the year.  This item also comprises direct costs for goods for resale and changes to inventory of goods for resale.</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCostOfSales><c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfOtherOperatingIncome contextRef="c405" xml:lang="en">Other operating income comprises items secondary to the activities of the Company, including gains on the disposal of property, plant and equipment.

Government grants are recognised when it is fairly certain that the grant conditions will be complied with, and the grant will be received.


Grants compensating for costs incurred are recognised directly as operating income in the income statement as costs eligible for grants are incurred. If the conditions for receiving the grant are not complied until after related costs have been recognised, the grant is to be recognised in the income statement when the conditions have been complied with and it is fairly certain that the grant will be awarded.

Grants to acquire assets are recognised in the balance sheet as deferred income/prepayments and transferred to other operating income in the income statement line with depreciation/amortisation of the assets covered by the grant.</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfOtherOperatingIncome><c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses contextRef="c405" xml:lang="en">Other external costs comprise costs of distribution, sales and advertising, administrative expenses, costs of premises, bad debts, operating leases, etc.</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses><c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEmployeeBenefitExpense contextRef="c405" xml:lang="en">Staff costs comprise wages and salaries, including holiday allowance, pension and other social security costs, etc., to the Company's employees, excluding reimbursements from public authorities.</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEmployeeBenefitExpense><c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses contextRef="c405" xml:lang="en">Financial income and expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme, etc.</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses><c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxExpenses contextRef="c405" xml:lang="en">Tax for the year comprises current corporation tax for the year and changes in deferred tax, including changes in tax rates. The tax expense relating to the profit/loss for the year is recognised in the income statement, and the tax expense relating to amounts directly recognised in equity is recognised directly in equity.</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxExpenses><c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfPropertyPlantAndEquipment contextRef="c405" xml:lang="en">Fixtures and fittings, tools, equipment and leasehold improvements are measured at cost less accumulated depreciation and impairment losses. 

Cost comprises the purchase price and any costs directly attributable to the acquisition until the date on which the asset is available for use.


The basis of depreciation is cost less any projected residual value after the end of the useful life. Depreciation is provided on a straight-line basis over the estimated useful life. The estimated useful lives are as follows:
The useful life and residual value are reassessed annually. Changes are treated as accounting estimates, and the effect on depreciation is recognised prospectively.</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfPropertyPlantAndEquipment><c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfPropertyPlantAndEquipment contextRef="c405">Fixtures and fittings, tools and equipment
5 years
Leasehold improvements
5 years</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfPropertyPlantAndEquipment><c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfInvestments contextRef="c405" xml:lang="en">Deposits are recognised at amortised cost.</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfInvestments><c:DescriptionOfMethodsOfAmortisationOfNoncurrentAssets contextRef="c405" xml:lang="en">The carrying amount of property, plant and equipment as well as deposits is subject to an annual test for indications of impairment other than the decrease in value reflected by depreciation or amortisation.

Impairment tests are conducted of individual assets or groups of assets when there is an indication that they may be impaired. Write-down is made to the recoverable amount if this is lower than the carrying amount.

The recoverable amount is the higher of an asset's net selling price and its value in use. The value in use is determined as the present value of the forecast net cash flows from the use of the asset or the group of assets, including forecast net cash flows from the disposal of the asset or the group of assets after the end of the useful life.</c:DescriptionOfMethodsOfAmortisationOfNoncurrentAssets><c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfInventories contextRef="c405" xml:lang="en">Inventories are measured at cost in accordance with the FIFO method. Where the net realisable value is lower than cost, inventories are written down to this lower value.

Finished goods and work in progress are measured at cost, comprising the cost of raw materials, consumables, direct wages and salaries and indirect production overheads. Indirect production overheads comprise indirect materials and wages and salaries as well as the maintenance of depreciation of production machinery, buildings and equipment as well as factory administration and management. Borrowing costs are not included in cost.

The net realisable value of inventories is calculated as the sales amount less costs of completion and costs necessary to make the sale and is determined taking into account marketability, obsolescence and development in expected selling price.</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfInventories><c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfReceivables contextRef="c405" xml:lang="en">Receivables are measured at amortised cost.

Write-down is made for bad debt losses where there is an objective indication that a receivable has been impaired. If there is an objective indication that an individual receivable has been impaired, write-down is made on an individual basis.

Write-downs are calculated as the difference between the carrying amount of receivables and the present value of forecast cash flows, including the realisable value of any collateral received. The effective interest rate for the individual receivable or portfolio is used as discount rate.</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfReceivables><c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeAssets contextRef="c405" xml:lang="en">Prepayments comprise prepayment of costs incurred relating to subsequent financial years.</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeAssets><c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxPayablesAndDeferredTax contextRef="c405" xml:lang="en">Current tax payable and receivable is recognised in the balance sheet as tax computed on the taxable income for the year, adjusted for tax on the taxable income of prior years and  for tax paid on account.

Deferred tax is measured using the balance sheet liability method on all temporary differences between the carrying amount and the tax value of assets and liabilities based on the planned use of the asset or settlement of the liability. However, deferred tax is not recognised on temporary differences relating to goodwill non-deductible for tax purposes and on office premises and other items where the temporary differences arise at the date of acquisition without affecting either profit/loss or taxable income.

Deferred tax assets, including the tax value of tax loss carryforwards, are recognised at the expected value of their utilisation within the foreseeable future; either as a set-off against tax on future income or as a set-off against deferred tax liabilities in the same legal tax entity. Any deferred net assets are measured at net realisable value.

Deferred tax is measured in accordance with the tax rules and at the tax rates applicable at the balance sheet date when the deferred tax is expected to crystallise as current tax. Changes in deferred tax as a result of changes in tax rates are recognised in the income statement or equity, respectively.</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxPayablesAndDeferredTax><c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions contextRef="c405" xml:lang="en">Other liabilities are measured at amortised cost.</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions><c:DisclosureOfEmployeeBenefitsExpense contextRef="c405">Wages and salaries
4,507
3,732
Pensions
169
102

Other social security costs
29
31

4,705
3,865




Average number of full-time employees
13
10</c:DisclosureOfEmployeeBenefitsExpense><c:DisclosureOfTaxExpenses contextRef="c405">Deferred tax for the year
95
113


95
113
</c:DisclosureOfTaxExpenses><c:DisclosureOfEquity contextRef="c405" xml:lang="en">The contributed capital consists of 125 shares of a nominal value of DKK 1,000 each.
All shares rank equally.</c:DisclosureOfEquity><c:DisclosureOfContingentLiabilities contextRef="c405" xml:lang="en">The total rent obligations and assets pledged as security for bank connections can be specified on the following way:</c:DisclosureOfContingentLiabilities><c:DisclosureOfLiabilitiesUnderLeases contextRef="c405">DKK'000
31/8 2023
31/8 2022
Rent obligations
2,379
2,003</c:DisclosureOfLiabilitiesUnderLeases><!--000.001: Aktuel periode koncern/moder--><context id="c405"><entity><identifier scheme="http://www.dcca.dk/cvr">28106483</identifier></entity><period><startDate>2022-09-01</startDate><endDate>2023-08-31</endDate></period></context><!--000.020 Revisor 1 koncern/moder--><context id="c407"><entity><identifier scheme="http://www.dcca.dk/cvr">28106483</identifier></entity><period><startDate>2022-09-01</startDate><endDate>2023-08-31</endDate></period><scenario><xbrldi:typedMember dimension="g:IdentificationOfAuditorDimension"><g:auditorIdentifier>1</g:auditorIdentifier></xbrldi:typedMember></scenario></context><!--000.006: Forrige periode moder--><context id="c409"><entity><identifier scheme="http://www.dcca.dk/cvr">28106483</identifier></entity><period><startDate>2021-09-01</startDate><endDate>2022-08-31</endDate></period></context><!--000.013: Slutdato aktuel periode moder--><context id="c412"><entity><identifier scheme="http://www.dcca.dk/cvr">28106483</identifier></entity><period><instant>2023-08-31</instant></period></context><!--000.014: Slutdato forrige periode moder--><context id="c413"><entity><identifier scheme="http://www.dcca.dk/cvr">28106483</identifier></entity><period><instant>2022-08-31</instant></period></context><!--000.030 Direktør 1 koncern/moder--><context id="c428"><entity><identifier scheme="http://www.dcca.dk/cvr">28106483</identifier></entity><period><startDate>2022-09-01</startDate><endDate>2023-08-31</endDate></period><scenario><xbrldi:typedMember dimension="g:IdentificationOfMemberOfExecutiveBoardDimension"><g:memberOfBoardIdentifier>1</g:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--001.040 Bestyrelsesmedlem 1 koncern/moder--><context id="c434"><entity><identifier scheme="http://www.dcca.dk/cvr">28106483</identifier></entity><period><startDate>2022-09-01</startDate><endDate>2023-08-31</endDate></period><scenario><xbrldi:typedMember dimension="g:IdentificationOfMemberOfSupervisoryBoardDimension"><g:memberOfBoardIdentifier>1</g:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--001.041 Bestyrelsesmedlem 2 koncern/moder--><context id="c435"><entity><identifier scheme="http://www.dcca.dk/cvr">28106483</identifier></entity><period><startDate>2022-09-01</startDate><endDate>2023-08-31</endDate></period><scenario><xbrldi:typedMember dimension="g:IdentificationOfMemberOfSupervisoryBoardDimension"><g:memberOfBoardIdentifier>2</g:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--001.042 Bestyrelsesmedlem 3 koncern/moder--><context id="c436"><entity><identifier scheme="http://www.dcca.dk/cvr">28106483</identifier></entity><period><startDate>2022-09-01</startDate><endDate>2023-08-31</endDate></period><scenario><xbrldi:typedMember dimension="g:IdentificationOfMemberOfSupervisoryBoardDimension"><g:memberOfBoardIdentifier>3</g:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--502.003.003 Overført resultat / Aktuel periode / Moder--><context id="c447"><entity><identifier scheme="http://www.dcca.dk/cvr">28106483</identifier></entity><period><startDate>2022-09-01</startDate><endDate>2023-08-31</endDate></period><scenario><xbrldi:explicitMember dimension="c:ResultDistributionDimension">c:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--502.003.004 Overført resultat / Forrige periode / Moder--><context id="c448"><entity><identifier scheme="http://www.dcca.dk/cvr">28106483</identifier></entity><period><startDate>2021-09-01</startDate><endDate>2022-08-31</endDate></period><scenario><xbrldi:explicitMember dimension="c:ResultDistributionDimension">c:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--700.001.003: Selskabskapital / Aktuel periode / moder--><context id="c487"><entity><identifier scheme="http://www.dcca.dk/cvr">28106483</identifier></entity><period><startDate>2022-09-01</startDate><endDate>2023-08-31</endDate></period><scenario><xbrldi:explicitMember dimension="c:ClassesOfEquityDimension">c:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--700.001.007: Selskabskapital / Startdato aktuel periode / moder--><context id="c491"><entity><identifier scheme="http://www.dcca.dk/cvr">28106483</identifier></entity><period><instant>2022-09-01</instant></period><scenario><xbrldi:explicitMember dimension="c:ClassesOfEquityDimension">c:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--700.001.011: Selskabskapital / Slutdato aktuel periode / moder--><context id="c494"><entity><identifier scheme="http://www.dcca.dk/cvr">28106483</identifier></entity><period><instant>2023-08-31</instant></period><scenario><xbrldi:explicitMember dimension="c:ClassesOfEquityDimension">c:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--700.014.003: Overført resultat / Aktuel periode / moder--><context id="c617"><entity><identifier scheme="http://www.dcca.dk/cvr">28106483</identifier></entity><period><startDate>2022-09-01</startDate><endDate>2023-08-31</endDate></period><scenario><xbrldi:explicitMember dimension="c:ClassesOfEquityDimension">c:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--700.014.007: Overført resultat / Startdato aktuel periode / moder--><context id="c621"><entity><identifier scheme="http://www.dcca.dk/cvr">28106483</identifier></entity><period><instant>2022-09-01</instant></period><scenario><xbrldi:explicitMember dimension="c:ClassesOfEquityDimension">c:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--700.014.011: Overført resultat / Slutdato aktuel periode / moder--><context id="c624"><entity><identifier scheme="http://www.dcca.dk/cvr">28106483</identifier></entity><period><instant>2023-08-31</instant></period><scenario><xbrldi:explicitMember dimension="c:ClassesOfEquityDimension">c:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Monetary--><unit id="u14"><measure>iso4217:DKK</measure></unit><!--Integer--><unit id="u16"><measure>xbrli:pure</measure></unit></xbrl>
